NCT04075305 The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study Status RECRUITING Phase N/A
NCT04047602 Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study Status TERMINATED Phase NA
NCT04023669 Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors Status COMPLETED Phase PHASE1
NCT03972514 Observational Trial of the Impact of Radiation Dose in Children With Brain and Skull Base Tumors. Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03925246 Efficacy of Nivolumab for Recurrent IDH Mutated High-Grade Gliomas Status COMPLETED Phase PHASE2
NCT03861299 The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients. Status RECRUITING Phase NA
NCT03629964 Study to Develop Head Stabilizer for Use During Brain Radiation Therapy Status WITHDRAWN Phase NA
NCT03538587 Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers Status COMPLETED Phase NA
NCT03465618 A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03434262 SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors Status COMPLETED Phase PHASE1
NCT03403361 Dual-Energy CT on Plan Quality, Dose-delivery Accuracy, and Simulated Outcomes of Patients Treated With Proton or Photon Therapy Status TERMINATED Phase NA
NCT03294486 Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients Status UNKNOWN Phase PHASE1/PHASE2
NCT03213002 Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM Status RECRUITING Phase PHASE1/PHASE2
NCT03190967 T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery Status TERMINATED Phase PHASE1/PHASE2
NCT03170141 Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme Status ENROLLING_BY_INVITATION Phase PHASE1
NCT03152318 A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 Status ACTIVE_NOT_RECRUITING Phase PHASE1